Survival and Prognostic Factors in Thyroid Carcinoma

Authors

  • H. Joensuu Departments of Radiation Therapy and Pathology, University Central Hospital of Turku, Turku, Finland; The Department of Biostatistics, University of Turku, Turku, Finland
  • P. J. Klemi Departments of Radiation Therapy and Pathology, University Central Hospital of Turku, Turku, Finland; The Department of Biostatistics, University of Turku, Turku, Finland
  • R. Paul Departments of Radiation Therapy and Pathology, University Central Hospital of Turku, Turku, Finland; The Department of Biostatistics, University of Turku, Turku, Finland
  • J. Tuominen Departments of Radiation Therapy and Pathology, University Central Hospital of Turku, Turku, Finland; The Department of Biostatistics, University of Turku, Turku, Finland

DOI:

https://doi.org/10.3109/02841868609136413

Keywords:

Thyroid neoplasms, carcinoma, prognostic factors

Abstract

A multivariate analysis of prognostic factors and survival was carried out in a series of 200 patients with thyroid carcinoma. The cumulative survival rate corrected for intercurrent deaths was higher for papillary carcinoma than for follicular carcinoma both at 5 years (92 % vs 74 %) and at ten years (87 % vs 66 %) after the diagnosis. Seventeen of the eighteen patients with anaplastic carcinoma died within 24 months after the diagnosis. The most important independent prognostic factor in patients with papillary or follicular carcinoma, by multivariate analysis, was age at time of diagnosis, followed by tumor penetration beyond the thyroid capsule and follicular histologic type. When different types of treatment were included in the analysis, age at diagnosis still remained the most important prognostic factor. Misdiagnosed intercurrent deaths in the elderly did not explain the negative effect of age on survival.

Downloads

Download data is not yet available.

Downloads

Published

1986-01-01

How to Cite

Joensuu, H., Klemi, P. J., Paul, R., & J. Tuominen. (1986). Survival and Prognostic Factors in Thyroid Carcinoma. Acta Oncologica, 25(4-6), 243–248. https://doi.org/10.3109/02841868609136413